Well this should reduce Medicare & ACA spending: Semaglutide Has Disproportionate Suicidality Signal, Analysis Finds

[Duaine]

Reports of suicidal ideation higher when compared to other drugs in WHO database.​

A disproportionality analysis based on reports in a World Health Organization (WHO) database suggested a suicidal ideation signal with the GLP-1 receptor agonist semaglutide (Ozempic, Rybelsus, Wegovy).

Between 2000 and 2023, semaglutide had 45% higher odds of suicidal ideation reports compared with all other drugs in the WHO database (reporting odds ratio [ROR] 1.45, 95% CI 1.18-1.77), according to Georgios Schoretsanitis, MD, PhD, of the Zucker Hillside Hospital in Glen Oaks, New York, and colleagues.

The finding "warrants urgent clarification," the researchers wrote in JAMA Network Openopens in a new tab or window.
[EXTERNAL LINK] - Semaglutide Has Disproportionate Suicidality Signal, Analysis Finds